Sign in

CIK 0001570562 · Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
461385614
Phone
(949) 284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 4 Open-market sale See Remarks sold 3,119 shares at $4.75 ($14,815)
  3. 4 Planned sale See Remarks sold 13,669 shares at $4.75 ($64,929)
  4. 4 Planned sale See Remarks sold 116,720 shares at $4.89 ($570,562)
  5. 4 Planned sale See Remarks sold 29,996 shares at $4.89 ($146,629)
  6. 8-K Event Executive or director change
  7. S-8 Other Securities Offered to Employees in Benefit Plans
  8. 10-K Report Annual Report
  9. 8-K Event Material agreement · Results of operations · New debt or obligation
  10. 4 Grant or award Director acquired 45,559 shares (grant or award)
  11. 4 Grant or award Director acquired 45,559 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 121,489 shares (grant or award)
  13. 4 Grant or award Director acquired 45,559 shares (grant or award)
  14. 4 Grant or award See Remarks acquired 313,212 shares (grant or award)
  15. 4 Grant or award Director acquired 45,559 shares (grant or award)
  16. 4 Grant or award See Remarks acquired 94,913 shares (grant or award)
  17. 4 Grant or award Director acquired 45,559 shares (grant or award)
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 2 of 28 · 558 filings